Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A mitochondria-specific mutational signature of aging: increased rate of A > G substitutions on the heavy strand.
Mikhailova AG, Mikhailova AA, Ushakova K, Tretiakov EO, Iliushchenko D, Shamansky V, Lobanova V, Kozenkov I, Efimenko B, Yurchenko AA, Kozenkova E, Zdobnov EM, Makeev V, Yurov V, Tanaka M, Gostimskaya I, Fleischmann Z, Annis S, Franco M, Wasko K, Denisov S, Kunz WS, Knorre D, Mazunin I, Nikolaev S, Fellay J, Reymond A, Khrapko K, Gunbin K, Popadin K. Mikhailova AG, et al. Among authors: iliushchenko d. Nucleic Acids Res. 2022 Oct 14;50(18):10264-10277. doi: 10.1093/nar/gkac779. Nucleic Acids Res. 2022. PMID: 36130228 Free PMC article.
Deciphering the Foundations of Mitochondrial Mutational Spectra: Replication-Driven and Damage-Induced Signatures Across Chordate Classes.
Iliushchenko D, Efimenko B, Mikhailova AG, Shamanskiy V, Saparbaev MK, Matkarimov BT, Mazunin I, Voronka A, Knorre D, Kunz WS, Kapranov P, Denisov S, Fellay J, Khrapko K, Gunbin K, Popadin K. Iliushchenko D, et al. Mol Biol Evol. 2025 Feb 3;42(2):msae261. doi: 10.1093/molbev/msae261. Mol Biol Evol. 2025. PMID: 39903101 Free PMC article.
Immunogenicity, efficacy and safety of a biosimilar insulin glulisine compared with originator in adults with type 1 diabetes mellitus: A phase III randomised clinical trial.
Drai R, Galstyan G, Karonova T, Protsenko E, Parfenova T, Arefeva A, Matvienko I, Iliushchenko D, Makarenko I. Drai R, et al. Among authors: iliushchenko d. Diabetes Obes Metab. 2026 Mar;28(3):1791-1799. doi: 10.1111/dom.70360. Epub 2025 Dec 9. Diabetes Obes Metab. 2026. PMID: 41366610 Clinical Trial.